Now bank­rupt, Zosano sells off its drug de­liv­ery tech that once en­ticed No­vo Nordisk, Eli Lil­ly

Clos­ing out the fi­nal chap­ter of its wind­ing 16-year his­to­ry, Zosano Phar­ma has sold all of its re­main­ing as­sets — in­clud­ing the in­tra­der­mal drug de­liv­ery sys­tem the com­pa­ny was built on.

Emergex Vac­cines, an in­fec­tious dis­ease play­er work­ing out of Abing­don, UK, is get­ting it all: the mi­cronee­dle ar­ray patch tech, in­tel­lec­tu­al prop­er­ty, li­cense agree­ments as well as spe­cial­ized man­u­fac­tur­ing equip­ment. That in­cludes every­thing from mi­cronee­dle coat­ing and reusable ap­pli­ca­tors to prod­uct pack­ag­ing and for­mu­la­tion know-how.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER